The nation of Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' insistence on sensitive information.
The decision was revealed following a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesperson has since stated that the US was demanding access to genetic material for scientific study and commercial gain but was unwilling to guarantee the benefits from any future treatments.
"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to secure a deal agreeable to both sides so the country's critical HIV programme can continue.
Broader Background
This development comes after a similar case in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and responsibility.
As per reports, Sixteen nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our population should a future pandemic arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending systems already set up through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how future co-operation might be structured in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body stated it acknowledged the government's concerns, but recommended that negotiations need to persist given that much of the nation's Aids initiatives relied on international support.
"If technical issues exist, such as those relating to information security or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group commented.
The situation highlights the continuing debate between receiving crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.